Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04088032 |
| Title | Neoadjuvant Study of Abemaciclib, Durvalumab, and an Aromatase Inhibitor Early Stage Breast Cancer |
| Recruitment | Withdrawn |
| Gender | female |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Alison Stopeck |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Stony Brook University Cancer Center | Stony Brook | New York | 11794 | United States | Details |